Variable | All patients (n = 146) | Patent (n = 109) | Thrombosed (n = 37) | P-value |
---|---|---|---|---|
Age, year, median (range) | 62 (42–82) | 63 (42–82) | 60 (43–78) | 0.052 |
Male, n (%) | 76 (52.1) | 58 (53.2) | 18 (48.6) | 0.631 |
MPV reconstruction technique, n (%) | 0.008 | |||
FL | 13 (8.9) | 13 (11.9) | 0 (0.0) | |
Primary | 30 (20.5) | 27 (24.8) | 3 (8.1) | |
LV | 19 (13.0) | 13 (11.9) | 6 (16.2) | |
PTFE | 24 (16.4) | 13 (11.9) | 11 (29.7) | |
IA | 47 (32.2) | 32 (29.4) | 15 (40.5) | |
PV | 13 (8.9) | 11 (10.1) | 2 (5.4) | |
Operation time, min, median (range) | 515 (242–921) | 450 (242–790) | 680 (250–921) | 0.000 |
Blood loss, ml, median (range) | 463 (100–2000) | 415 (100–1500) | 581 (100–2000) | 0.037 |
Intraoperative transfusion, n (%) | 25 (17.1) | 15 (13.8) | 10 (27.0) | 0.064 |
Postoperative pathology | ||||
Tumor differentiation, n (%) | 0.514 | |||
Poor | 82 (56.2) | 63 (57.8) | 19 (51.4) | |
Moderate | 62 (42.5) | 44 (40.4) | 18 (48.6) | |
Well | 2 (1.4) | 2 (1.8) | 0 (0.0) | |
Tumor size, cm, median (range) | 3.4 (1–10) | 3.4 (1–10) | 3.4 (1–8) | 0.919 |
Lymph node metastasis, n (%) | 88 (60.3) | 60 (55.0) | 28 (75.7) | 0.027 |
R0 resection, n (%) | 129 (88.4) | 97 (89.0) | 32 (86.5) | 0.682 |
Postoperative complications, n (%) | ||||
Pancreatic fistula | 28 (19.2) | 16 (14.7) | 12 (32.4) | 0.018 |
Bleed | 11 (7.5) | 5 (4.6) | 6 (16.2) | 0.031 |
Delayed gastric emptying | 13 (8.9) | 10 (9.2) | 3 (8.1) | 0.844 |
Postoperative abdominal infection | 13 (8.9) | 7 (6.4) | 6 (16.2) | 0.071 |
Unplanned relaparotomy, n (%) | 8 (5.5) | 3 (2.8) | 5 (13.5) | 0.025 |
Mortality within 90 days, n (%) | 3 (2.1) | 2 (1.8) | 1 (2.7) | 1.000 |
Antiplatelet/anticoagulation, n (%) | 78 (53.4) | 57 (52.3) | 21 (56.8) | 0.638 |
Postoperative hospital stay, day, median (range) | 21.4 (10–62) | 19.5 (10–49) | 25.7 (10–62) | 0.026 |